Cas no 39011-91-1 (Oxypaeoniflorin)
Oxypaeoniflorin Chemical and Physical Properties
Names and Identifiers
-
- Oxypaeoniflora
- Oxypaeoniflorin
- [(1aR,2S,3aR,5R,5aR,5bS)-1a-(beta-D-glucopyranosyloxy)-5-hydroxy-2-methyltetrahydro-1H-2,5-methano-3,4-dioxacyclobuta[cd]pentalen-5b(3aH)-yl]methyl 4-hydroxybenzoate
- [ "" ]
- [(1R,5R,6R,8S)-6-Hydroxy-8-methyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]ox
- 3A7O4NBD5S
- X1196
- 011O911
- Q27256957
- beta-D-Glucopyranoside, tetrahydro-5-hydroxy-5b-(((4-hydroxybenzoyl)oxy)methyl)-2-methyl-2,5-methano-1H-3,4-dioxacyclobuta(cd)pentalen-1a(2H)-yl, (1aR-(1aalpha,2beta,3aalpha,5alpha,5a
- AKOS037514765
- 39011-91-1
- [(2S,3R,5R,6R,8S)-6-Hydroxy-8-methyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-9,10-dioxatetracyclo[4.3.1.02,5.03,8]decan-2-yl]methyl 4-hydroxybenzoate
- Paeonin C
- (+)-Paeonin C
- NSC258310
- DTXSID30959855
- [1a-(Hexopyranosyloxy)-5-hydroxy-2-methyltetrahydro-1H-2,5-methano-3,4-dioxacyclobuta[cd]pentalen-5b(3aH)-yl]methyl 4-hydroxybenzoate
- AKOS015896757
- [6-hydroxy-8-methyl-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-9,10-dioxatetracyclo[4.3.1.02,5.03,8]decan-2-yl]methyl 4-hydroxybenzoate
- NCGC00482893-01
- FT-0689397
- SCHEMBL21315810
- [(1R,2S,3R,5R,6R,8S)-6-hydroxy-8-methyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-9,10-dioxatetracyclo[4.3.1.02,5.03,8]decan-2-yl]methyl 4-hydroxybenzoate
- MS-29219
- CHEBI:132789
- NSC-258310
- .BETA.-D-GLUCOPYRANOSIDE, TETRAHYDRO-5-HYDROXY-5B-(((4-HYDROXYBENZOYL)OXY)METHYL)-2-METHYL-2,5-METHANO-1H-3,4-DIOXACYCLOBUTA(CD)PENTALEN-1A(2H)-YL, (1AR-(1A.ALPHA.,2.BETA.,3A.ALPHA.,5.ALPHA.,5A.ALPHA.,5B.ALPHA.))-
- MFCD00869478
- (((1AR)-3A.BETA.,5,5A.BETA.,5B-TETRAHYDRO-5.BETA.-HYDROXY-5B.BETA.-(((4-HYDROXYBENZOYL)OXY)METHYL)-2-METHYL-2.ALPHA.,5-METHANO-3,4-DIOXA-1H-CYCLOBUTA(CD)PENTALEN)-1A.BETA.(2H)-YL).BETA.-D-GLUCOPYRANOSIDE
- SCHEMBL4087053
- [1aR-(1a?,2?,3a?,5?,5a?,5b?)]-Tetrahydro-5-hydroxy-5b-[[(4-hydroxybenzoyl)oxy]methyl]-2-methyl-2,5-methano-1H-3,4-dioxacyclobuta[cd]pentalen-1a(2H)-yl-?-D-Glucopyranoside; 2,5-Methano-1H-3,4-dioxacyclobuta[cd]pentalene ?-D-Glucopyranoside deriv.; NSC 258310; Oxypaeoniflorin; Oxypeoniflorin
- J17.727J
- ((2S,3R,5R,6R,8S)-3-(.BETA.-D-GLUCOPYRANOSYLOXY)-6-HYDROXY-8-METHYL-9,10-DIOXATETRACYCLO(4.3.1.02,5.03,8)DEC-2-YL)METHYL 4-HYDROXYBENZOATE
- ((2S,3R,5R,6R,8S)-3-(beta-D-GLUCOPYRANOSYLOXY)-6-HYDROXY-8-METHYL-9,10-DIOXATETRACYCLO(4.3.1.02,5.03,8)DEC-2-YL)METHYL 4-HYDROXYBENZOATE
- beta-D-GLUCOPYRANOSIDE, (1AR,2S,3AR,5R,5AR,5BS)-TETRAHYDRO-5-HYDROXY-5B-(((4-HYDROXYBENZOYL)OXY)METHYL)-2-METHYL-2,5-METHANO-1H-3,4-DIOXACYCLOBUTA(CD)PENTALEN-1A(2H)-YL
- CS-3645
- NSC 258310
- beta-D-Glucopyranoside, tetrahydro-5-hydroxy-5b-(((4-hydroxybenzoyl)oxy)methyl)-2-methyl-2,5-methano-1H-3,4-dioxacyclobuta(cd)pentalen-1a(2H)-yl, (1aR-(1aalpha,2beta,3aalpha,5alpha,5aalpha,5balpha))-
- NS00093950
- AKOS040756009
- UNII-3A7O4NBD5S
- OXYPEONIFLORIN
- CHEMBL4871716
- (((1AR)-3Abeta,5,5Abeta,5B-TETRAHYDRO-5beta-HYDROXY-5Bbeta-(((4-HYDROXYBENZOYL)OXY)METHYL)-2-METHYL-2alpha,5-METHANO-3,4-DIOXA-1H-CYCLOBUTA(CD)PENTALEN)-1Abeta(2H)-YL)beta-D-GLUCOPYRANOSIDE
- .BETA.-D-GLUCOPYRANOSIDE, (1AR,2S,3AR,5R,5AR,5BS)-TETRAHYDRO-5-HYDROXY-5B-(((4-HYDROXYBENZOYL)OXY)METHYL)-2-METHYL-2,5-METHANO-1H-3,4-DIOXACYCLOBUTA(CD)PENTALEN-1A(2H)-YL
- HY-N0748
- AC-34571
- GLXC-14308
-
- Inchi： 1S/C23H28O12/c1-20-8-22(30)13-6-23(20,33-18-16(28)15(27)14(26)12(7-24)32-18)21(13,19(34-20)35-22)9-31-17(29)10-2-4-11(25)5-3-10/h2-5,12-16,18-19,24-28,30H,6-9H2,1H3/t12-,13-,14-,15+,16-,18+,19-,20+,21+,22-,23+/m1/s1
- InChI Key： FCHVXNVDFYXLIL-WRJNSLSBSA-N
- SMILES： O1[C@]2([H])[C@]3(COC(=O)C4=CC=C(O)C=C4)[C@@]4([C@]1(C[C@]([C@]3(C4)O[C@]1([C@H](O)[C@@H](O)[C@@H]([C@@H](CO)O1)O)[H])(C)O2)O)[H]
Computed Properties
- Exact Mass: 496.15800
- Monoisotopic Mass: 496.15807632 g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 6
- Hydrogen Bond Acceptor Count: 12
- Heavy Atom Count: 35
- Rotatable Bond Count: 7
- Complexity: 879
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 10
- Undefined Atom Stereocenter Count : 1
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Molecular Weight: 496.5
- XLogP3: -1.4
- Topological Polar Surface Area: 185
Experimental Properties
- Color/Form: Powder
- Melting Point: No data available
- Boiling Point: 737.1±60.0 °C at 760 mmHg
- Flash Point: 254.6±26.4 °C
- PSA: 184.60000
- LogP: -1.65190
Oxypaeoniflorin Security Information
- Signal Word：warning
- Hazard Statement： H303May be harmful if swallowed+H313Skin contact may be harmful+H333Inhalation may be harmful to the body
-
Warning Statement：
P264Thoroughly clean after treatment
P280Wear protective gloves/Wear protective clothing/Wear protective goggles/Wear a protective mask
P305If it enters the eyes
P351Rinse carefully with water for a few minutes
P338Remove the contact lens(If any)And easy to operate,Continue flushing
P337If eye irritation persists
P313Obtain medical advice/care - Safety Instruction： H303May be harmful if swallowed+H313Skin contact may be harmful+H333Inhalation may be harmful to the body
- Storage Condition：Powder -20°C 3 years ? 4°C 2 years In solvent -80°C 6 months ? -20°C 1 month
Oxypaeoniflorin Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| XI GE MA AO DE LI QI （ SHANG HAI ） MAO YI Co., Ltd. | PHL80608-10MG |
Oxypaeoniflorin |
39011-91-1 | 10mg |
￥6947.41 | 2023-09-09 | ||
| TRC | O876900-10mg |
Oxypaeoniflora |
39011-91-1 | 10mg |
$ 173.00 | 2023-09-06 | ||
| TRC | O876900-100mg |
Oxypaeoniflora |
39011-91-1 | 100mg |
$ 1367.00 | 2023-09-06 | ||
| Chengdu Biopurify Phytochemicals Ltd | BP1050-20mg |
Oxypaeoniflorin |
39011-91-1 | 98% | 20mg |
$160 | 2023-09-20 | |
| Chengdu Biopurify Phytochemicals Ltd | BP1050-10mg |
Oxypaeoniflorin |
39011-91-1 | 98% | 10mg |
$96 | 2023-09-20 | |
| SHANG HAI TAO SHU Biotechnology Co., Ltd. | T3773-1 mg |
Oxypaeoniflorin |
39011-91-1 | 98.33% | 1mg |
￥432.00 | 2022-02-28 | |
| SHANG HAI TAO SHU Biotechnology Co., Ltd. | T3773-2 mg |
Oxypaeoniflorin |
39011-91-1 | 98.33% | 2mg |
￥777.00 | 2022-02-28 | |
| SHANG HAI TAO SHU Biotechnology Co., Ltd. | T3773-5 mg |
Oxypaeoniflorin |
39011-91-1 | 98.33% | 5mg |
￥1399.00 | 2022-02-28 | |
| SHANG HAI TAO SHU Biotechnology Co., Ltd. | T3773-10 mg |
Oxypaeoniflorin |
39011-91-1 | 98.33% | 10mg |
￥2440.00 | 2022-02-28 | |
| SHANG HAI TAO SHU Biotechnology Co., Ltd. | T3773-25 mg |
Oxypaeoniflorin |
39011-91-1 | 98.33% | 25mg |
￥4392.00 | 2022-02-28 |
Oxypaeoniflorin Suppliers
Audited Supplier
Audited Supplier
Oxypaeoniflorin Related Literature
-
Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
-
Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
-
Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622
-
Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
-
Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
Additional information on Oxypaeoniflorin
Oxypaeoniflorin (CAS No. 39011-91-1): A Comprehensive Guide to Its Properties and Applications
Oxypaeoniflorin (CAS No. 39011-91-1) is a bioactive monoterpene glycoside derived from the roots of Paeonia lactiflora, commonly known as white peony. This compound has garnered significant attention in recent years due to its potential therapeutic properties, particularly in traditional Chinese medicine (TCM) and modern pharmacology. As researchers continue to explore its mechanisms of action, Oxypaeoniflorin has become a focal point for studies on neuroprotection, anti-inflammatory effects, and metabolic regulation.
The chemical structure of Oxypaeoniflorin features a unique combination of a monoterpene skeleton and a glucose moiety, which contributes to its solubility and bioavailability. This structural characteristic is often compared to other well-known glycosides like paeoniflorin, though Oxypaeoniflorin exhibits distinct pharmacological activities. Recent studies highlight its role in modulating oxidative stress and inflammatory pathways, making it a promising candidate for managing conditions such as neurodegenerative diseases and autoimmune disorders.
One of the most searched questions about Oxypaeoniflorin is its potential benefits for brain health. Emerging research suggests that this compound may support cognitive function by reducing neuroinflammation and promoting neuronal survival. These findings align with the growing consumer interest in nootropics and natural cognitive enhancers, positioning Oxypaeoniflorin as a valuable ingredient in brain health supplements.
In the realm of skincare, Oxypaeoniflorin is gaining traction for its anti-aging and anti-inflammatory properties. With the rise of "clean beauty" trends, consumers are increasingly seeking plant-derived actives that offer scientifically backed benefits. Oxypaeoniflorin fits this demand, as it has been shown to inhibit collagen degradation and reduce redness, making it a potential star ingredient in serums and creams targeting sensitive or aging skin.
The market for Oxypaeoniflorin is expanding, particularly in the nutraceutical and cosmeceutical sectors. Suppliers and manufacturers are responding to this demand by offering high-purity extracts standardized for Oxypaeoniflorin content. Quality control is critical, as variations in extraction methods can significantly impact the compound's efficacy. Analytical techniques such as HPLC are commonly employed to verify the purity and concentration of Oxypaeoniflorin in commercial products.
Another hot topic surrounding Oxypaeoniflorin is its potential role in metabolic health. Preliminary studies indicate that it may influence glucose metabolism and insulin sensitivity, sparking interest in its application for metabolic syndrome management. This aligns with the global focus on preventive healthcare and natural approaches to chronic disease management.
For researchers working with Oxypaeoniflorin, understanding its stability profile is essential. The compound is sensitive to light and heat, requiring proper storage conditions to maintain its integrity. This characteristic has led to innovations in encapsulation technologies to enhance its stability in formulated products.
As interest in plant-based medicine continues to grow, Oxypaeoniflorin stands out as a compound bridging traditional knowledge and modern science. Its multifaceted biological activities and favorable safety profile make it a subject of ongoing research across multiple disciplines, from pharmacology to cosmetic science.
The future of Oxypaeoniflorin research looks promising, with clinical trials underway to validate its therapeutic potential in various applications. As more data emerges, we can expect to see this compound play an increasingly important role in both healthcare and wellness products, offering natural solutions aligned with contemporary health trends.
